CA2152676A1 - Epreuve permettant de distinguer chez les femmes sur le point d'accoucher celles chez qui il y a perte des eaux - Google Patents

Epreuve permettant de distinguer chez les femmes sur le point d'accoucher celles chez qui il y a perte des eaux

Info

Publication number
CA2152676A1
CA2152676A1 CA 2152676 CA2152676A CA2152676A1 CA 2152676 A1 CA2152676 A1 CA 2152676A1 CA 2152676 CA2152676 CA 2152676 CA 2152676 A CA2152676 A CA 2152676A CA 2152676 A1 CA2152676 A1 CA 2152676A1
Authority
CA
Canada
Prior art keywords
sample
igfbp
delivery
patient
membranes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2152676
Other languages
English (en)
Inventor
John C. Leavitt
David C. Casal
Madhu Varma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adeza Biomedical Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2152676A1 publication Critical patent/CA2152676A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA 2152676 1993-01-22 1994-01-21 Epreuve permettant de distinguer chez les femmes sur le point d'accoucher celles chez qui il y a perte des eaux Abandoned CA2152676A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US743293A 1993-01-22 1993-01-22
US007,432 1993-01-22

Publications (1)

Publication Number Publication Date
CA2152676A1 true CA2152676A1 (fr) 1994-08-04

Family

ID=21726119

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2152676 Abandoned CA2152676A1 (fr) 1993-01-22 1994-01-21 Epreuve permettant de distinguer chez les femmes sur le point d'accoucher celles chez qui il y a perte des eaux

Country Status (4)

Country Link
EP (1) EP0680607A4 (fr)
JP (3) JP3742649B2 (fr)
CA (1) CA2152676A1 (fr)
WO (1) WO1994017405A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026734A1 (fr) * 1994-04-04 1995-10-12 Freeman William R Emploi de nucleosides de phosphonylemethoxyalkyle pour traiter la pression intra-oculaire elevee
US5597700A (en) * 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
US6678669B2 (en) 1996-02-09 2004-01-13 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
BR9809713A (pt) 1997-05-30 2000-07-11 Sankyo Co Composto, medicamento e composição compreendendo o mesmo, uso do composto, e, processos para profilaxia ou tratamento de doenças mediadas com taquicinina, para inibir um receptor nk1 e/ou um receptor nk2, e para profilaxia ou tratamento de asma e/ou bronquite, de rinite, de alergia, e, de incontinência urinária
RU2156469C1 (ru) * 1999-04-02 2000-09-20 Уральский НИИ охраны материнства и младенчества Способ прогноза развития геморрагических осложнений в родах по данным системы гемостаза во второй половине беременности
US20040266025A1 (en) * 2003-02-06 2004-12-30 Durlin Hickok Screening and treatment methods for prevention of preterm delivery
DK2299275T3 (en) 2004-07-30 2018-05-07 Adeza Biomedical Corp Classification of oncofetal fetronectin level for pregnancy-related indications
WO2007030890A1 (fr) * 2005-09-15 2007-03-22 Bio Source (Wuhan) Technology Ltd Marqueur de la rupture prolongee des membranes
JP4952164B2 (ja) * 2006-09-20 2012-06-13 株式会社デンソー 流量計測素子、質量流量計
CN103543273A (zh) * 2013-11-04 2014-01-29 无锡博慧斯生物医药科技有限公司 一种孕妇早产胎儿纤维连接蛋白和磷酸化胰岛素样生长因子结合蛋白-1联检试剂盒
WO2017170824A1 (fr) * 2016-03-31 2017-10-05 積水メディカル株式会社 Procédé de détection de fibronectine oncofœtale par dosage immunologique simple
CN117957444A (zh) * 2021-08-30 2024-04-30 国立大学法人京都大学 检查方法和检查试剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337394C (fr) * 1987-11-17 1995-10-24 Nelson N. H. Teng Test a prelevement vaginal et reactifs
US5096830A (en) * 1987-11-17 1992-03-17 Adeza Biomedical Corporation Preterm labor and membrane rupture test
FI86777C (fi) * 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid

Also Published As

Publication number Publication date
JP3742649B2 (ja) 2006-02-08
JPH08506658A (ja) 1996-07-16
JP3943575B2 (ja) 2007-07-11
EP0680607A1 (fr) 1995-11-08
WO1994017405A1 (fr) 1994-08-04
JP2005326427A (ja) 2005-11-24
EP0680607A4 (fr) 1997-06-04
JP2004125807A (ja) 2004-04-22

Similar Documents

Publication Publication Date Title
US5516702A (en) Screening method for identifying women at increased risk for imminent delivery
EP0642667B1 (fr) Procede de depistage pour l'identification de femmes presentant un risque accru d'accouchement avant terme
EP1936376B1 (fr) Procédés de criblage et de traitement pour la prévention des accouchements prématurés
US5281522A (en) Reagents and kits for determination of fetal fibronectin in a vaginal sample
US7892774B2 (en) Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
US5096830A (en) Preterm labor and membrane rupture test
Klentzrics et al. Placental protein 14 in cycles with normal and retarded endometrial differentiation
US5468619A (en) Screening method for identifying women at increased risk for imminent delivery
JP3742649B2 (ja) 切迫分娩についての危険にある女性における膜の破裂を決定するための検定方法
Seif et al. A novel approach for monitoring the endometrial cycle and detecting ovulation
EP1914553A1 (fr) Procédé d'identification de femmes ayant un risque accru de retard de croissance fýtal
WO1993024836A1 (fr) Methode de depistage de femmes presentant un risque eleve d'accouchement avant terme
WO1993024838A1 (fr) Methode de depistage permettant de depister chez les femmes le risque d'accouchement avant terme
WO1999058974A1 (fr) Procede et dispositif de test d'evaluation de la maturite cervicale a terme avec des isoformes de igfpb-1 fortement phosphorylees
HK1119248B (en) Screening and treatment methods for prevention of preterm delivery
HK1119248A1 (en) Screening and treatment methods for prevention of preterm delivery
JPH10239311A (ja) 異常分娩の検出方法及び検出試薬

Legal Events

Date Code Title Description
FZDE Dead